Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Anemia

  Free Subscription


Articles published in Haematologica

Retrieve available abstracts of 153 articles:
HTML format



Single Articles


    June 2024
  1. MATTE A, Federti E, Recchiuti A, Hamza M, et al
    Epeleuton, a novel synthetic omega-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease.
    Haematologica. 2024;109:1918-1932.
    PubMed     Abstract available


    May 2024
  2. QUDEIMAT A, Suryaprakash S, Madden R, Srinivasan A, et al
    Reduced toxicity conditioning for hematopoietic stem cell transplantation in children with Diamond-Blackfan anemia.
    Haematologica. 2024 May 30. doi: 10.3324/haematol.2024.285147.
    PubMed     Abstract available


  3. KOO J, Howell JC, Hornung L, Sabulski A, et al
    Infrequent fractures and resilient bone mineral density: bone health in patients with Fanconi anemia.
    Haematologica. 2024 May 30. doi: 10.3324/haematol.2024.285612.
    PubMed     Abstract available


  4. ZAHR RS, Rashkin SR, Ruiz MA, Elsherif L, et al
    Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia.
    Haematologica. 2024 May 2. doi: 10.3324/haematol.2023.284920.
    PubMed     Abstract available


  5. PECKER LH, Federspiel J
    Sickle cell disease, pregnancy, and COVID-19 in France: plus ca change.
    Haematologica. 2024;109:1328-1330.
    PubMed    


  6. KAMINSKI TW, Katoch O, Li Z, Hanway CB, et al
    Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease.
    Haematologica. 2024;109:1535-1550.
    PubMed     Abstract available


  7. JOSEPH L, De Luna G, Bernit E, Cougoul P, et al
    A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.
    Haematologica. 2024;109:1562-1565.
    PubMed    


    April 2024
  8. CONNOR MP, Prathapa N, Frey NV, Gill SI, et al
    Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
    Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285275.
    PubMed     Abstract available


  9. GLENTHOJ A
    Beyond adenosine triphosphate: unveiling the pleiotropic effects of pyruvate kinase activation in sickle cell anemia.
    Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285390.
    PubMed     Abstract available


  10. OLIVIER E, Zhang S, Yan Z, Bouhassira EE, et al
    Stem cell factor and erythropoietin-independent production of cultured reticulocytes.
    Haematologica. 2024 Apr 11. doi: 10.3324/haematol.2023.284427.
    PubMed     Abstract available


  11. DENIS M, Swartzrock L, Willner H, Bubb QR, et al
    Hematopoiesis post anti-CD117 monoclonal antibody treatment in wild-type and Fanconi anemia settings.
    Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2023.284275.
    PubMed     Abstract available


  12. BOSE P, Masarova L, Pemmaraju N, Bledsoe SD, et al
    Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study.
    Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2023.284078.
    PubMed    


  13. DUBEY RK, Vats R, Brzoska T, Kaminski TW, et al
    Subcutaneous injection of IHP-102 prevents lung vaso-occlusion in sickle cell disease mice.
    Haematologica. 2024;109:1259-1263.
    PubMed    


    March 2024
  14. ZHANG Q, Lin P, Mao A, Liu Y, et al
    An unusual case of thalassemia intermedia with inheritable complex repeats detected by single-molecule optical mapping.
    Haematologica. 2024;109:1000-1006.
    PubMed    


  15. AL-SAMKARI H, Grace RF, Glenthoj A, Andres O, et al
    Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment.
    Haematologica. 2024;109:963-967.
    PubMed    


  16. RISITANO AM, Frieri C
    Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2024;109:704-708.
    PubMed    


  17. KULASEKARARAJ AG, Lehtinen AE, Forsyth C, Gandhi S, et al
    Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2024;109:929-935.
    PubMed    


    February 2024
  18. LU Y, Zhu Q, Wang Y, Luo M, et al
    Enhancement of PRMT6 binding to a novel germline GATA1 mutation associated with congenital anemia.
    Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.284183.
    PubMed     Abstract available


  19. XU ZL, Xu LP, Zhang YC, Zhou YH, et al
    The outcome and predictive model of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia from the Chinese Blood and Marrow Transplant Registry Group.
    Haematologica. 2024 Feb 1. doi: 10.3324/haematol.2023.284581.
    PubMed     Abstract available


  20. LIU Y, Zhuang Y, Chen J, Zhong Z, et al
    Quantitative evaluation of the clinical severity of hemoglobin H disease in a cohort of 591 patients using a scoring system based on regression analysis.
    Haematologica. 2024;109:632-638.
    PubMed    


    January 2024
  21. FOUDA RT, Cherukury HM, Kiven SB, Garcia NR, et al
    Colchicine reduces inflammation in a humanized transgenic murine model of sickle cell disease.
    Haematologica. 2024;109:308-311.
    PubMed    


  22. THILAKARATHNE S, Jayaweera UP, Premawardhena A
    Unresolved laboratory issues of the heterozygous state of beta-thalassemia: a literature review.
    Haematologica. 2024;109:23-32.
    PubMed     Abstract available


    December 2023
  23. RAJPUT RV, Shah V, Shalhoub RN, West-Mitchell K, et al
    Granulocyte transfusions in severe aplastic anemia.
    Haematologica. 2023 Dec 7. doi: 10.3324/haematol.2023.283826.
    PubMed     Abstract available


  24. D'ALESSANDRO A, Nouraie SM, Zhang Y, Cendali F, et al
    Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment.
    Haematologica. 2023;108:3418-3432.
    PubMed     Abstract available


  25. COLOMBATTI R, Casale M
    Early splenectomy in sickle cell disease: another piece of the puzzle.
    Haematologica. 2023;108:3197-3198.
    PubMed    


  26. YAMASHITA D, Muramatsu H, Narita A, Wakamatsu M, et al
    Hematological abnormalities in Jacobsen syndrome: cytopenia of varying severities and morphological abnormalities in peripheral blood and bone marrow.
    Haematologica. 2023;108:3438-3443.
    PubMed    


    November 2023
  27. ESPERTI S, Nader E, Stier A, Boisson C, et al
    Increased retention of functional mitochondria in mature sickle red blood cells is associated with increased sickling tendency, hemolysis and oxidative stress.
    Haematologica. 2023;108:3086-3094.
    PubMed     Abstract available


  28. TEFFERI A, Pardanani A, Gangat N
    Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis.
    Haematologica. 2023;108:2919-2932.
    PubMed     Abstract available


    October 2023
  29. GUERRA A, Parhiz H, Rivella S
    Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis.
    Haematologica. 2023;108:2582-2593.
    PubMed     Abstract available


  30. KALLEDA N, Flace A, Altermatt P, Ingoglia G, et al
    Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of beta-thalassemia with blood transfusions.
    Haematologica. 2023;108:2703-2714.
    PubMed     Abstract available


  31. VERSTOVSEK S, Foltz L, Gupta V, Hasserjian R, et al
    Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
    Haematologica. 2023;108:2730-2742.
    PubMed     Abstract available


    September 2023
  32. DEZERN AE, Zahurak M, Jones RJ, Brodsky RA, et al
    Uniform conditioning regardless of donor in bone marrow transplantation for severe aplastic anemia.
    Haematologica. 2023 Sep 7. doi: 10.3324/haematol.2023.284022.
    PubMed     Abstract available


  33. BROUSSE V, Bernaudin F, Melaine A, Goguillot M, et al
    Severity and burden of sickle cell disease in France: a nationwide real-world study.
    Haematologica. 2023;108:2476-2486.
    PubMed     Abstract available


  34. MATTE A, Kosinski PA, Federti E, Dang L, et al
    Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in beta-thalassemic mice.
    Haematologica. 2023;108:2535-2541.
    PubMed    


    August 2023
  35. GRIFFIN M, Eikema DJ, Verheggen I, Kulagin A, et al
    SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2023 Aug 16. doi: 10.3324/haematol.2023.283863.
    PubMed    


  36. CIUDAD M, Ouandji S, Lamarthee B, Cladiere C, et al
    Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor alpha in autoimmune hemolytic anemia and participate in Th17 polarization.
    Haematologica. 2023 Aug 3. doi: 10.3324/haematol.2023.282859.
    PubMed     Abstract available


    July 2023
  37. BACIGALUPO A
    Long term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?
    Haematologica. 2023 Jul 13. doi: 10.3324/haematol.2023.283523.
    PubMed     Abstract available


  38. ALKOBTAWI M, Sbeih M, Souaid K, Ngo QT, et al
    Contribution of fetal microchimeric cells to maternal wound healing in sickle cell ulcers.
    Haematologica. 2023;108:1920-1933.
    PubMed     Abstract available


    June 2023
  39. DROR Y
    Correcting the aberrant Fanconi anemia transcriptional program by gene therapy.
    Haematologica. 2023 Jun 8. doi: 10.3324/haematol.2023.283031.
    PubMed     Abstract available


  40. NAKAMURA R, Patel BA, Kim S, Wong FL, et al
    Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy.
    Haematologica. 2023 Jun 1. doi: 10.3324/haematol.2023.282781.
    PubMed     Abstract available


    May 2023
  41. MECHRAOUI A, Ithier G, Pages J, Haouari Z, et al
    Early splenectomy in a large cohort of children with sickle cell anemia: risks and consequences.
    Haematologica. 2023 May 25. doi: 10.3324/haematol.2022.282556.
    PubMed     Abstract available


  42. LIU Y, Schmiderer L, Hjort M, Lang S, et al
    Engineered human Diamond-Blackfan anemia disease model confirms therapeutic effects of clinically applicable lentiviral vector at single-cell resolution.
    Haematologica. 2023 May 18. doi: 10.3324/haematol.2022.282068.
    PubMed     Abstract available


  43. PAGLIUCA S, Kulasekararaj AG, Eikema DJ, Piepenbroek B, et al
    Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation.
    Haematologica. 2023 May 18. doi: 10.3324/haematol.2023.282935.
    PubMed     Abstract available


  44. FEDERTI E, Vinchi F, Iatcenko I, Ghigo A, et al
    Duality of Nrf2 in iron-overload cardiomyopathy.
    Haematologica. 2023;108:1335-1348.
    PubMed     Abstract available


  45. ATAGA KI, Zhou Q, Saraf SL, Hankins JS, et al
    Sex differences in progression of kidney disease in sickle cell disease.
    Haematologica. 2023;108:1436-1441.
    PubMed    


  46. WANG L, Liu S, Luo J, Mo Q, et al
    Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
    Haematologica. 2023;108:1394-1411.
    PubMed     Abstract available


  47. KULASEKARARAJ A, Brodsky R, Kulagin A, Jang JH, et al
    Biosimilars in rare diseases: a focus on paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2023;108:1232-1243.
    PubMed     Abstract available


    April 2023
  48. ROSATO BE, Marra R, Del Giudice F, Nostroso A, et al
    One gene, two opposite phenotypes: a case report of hereditary anemia due to a loss-offunction variant in the EPAS1 gene.
    Haematologica. 2023 Apr 27. doi: 10.3324/haematol.2022.282457.
    PubMed     Abstract available


  49. LASAGA M, Rio P, Vilas-Zornoza A, Planell N, et al
    Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.
    Haematologica. 2023 Apr 6. doi: 10.3324/haematol.2022.282418.
    PubMed     Abstract available


  50. NARDO-MARINO A, Brousse V
    Splenectomy in sickle cell disease: do benefits outweigh risks?
    Haematologica. 2023;108:954-955.
    PubMed    


  51. PINTO VM, Gianesin B, Piel FB, Longo F, et al
    Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting.
    Haematologica. 2023;108:1158-1162.
    PubMed    


    March 2023
  52. DEVILLIER R, Eikema DJ, Dufour C, Aljurf M, et al
    Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.
    Haematologica. 2023 Mar 23. doi: 10.3324/haematol.2022.281876.
    PubMed     Abstract available


  53. KOO J, Grom-Mansencal I, Howell JC, Rios JM, et al
    Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant.
    Haematologica. 2023 Mar 9. doi: 10.3324/haematol.2022.282094.
    PubMed     Abstract available


  54. GALINDO-NAVARRO P, Delgado-Garcia A, Rodriguez-Gil MA, Puerta-Puerta JM, et al
    Venetoclax for treating refractory autoimmune hemolytic anemia in chronic lymphocytic leukemia: report of two cases in Spain.
    Haematologica. 2023 Mar 2. doi: 10.3324/haematol.2022.281850.
    PubMed     Abstract available


  55. JASH A, Howie HL, Hay AM, Luckey CJ, et al
    Identification of multiple genetic loci associated with red blood cell alloimmunization in mice.
    Haematologica. 2023;108:905-908.
    PubMed    


  56. FALGUIERE C, Allali S, Khazem B, Kamdem A, et al
    Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France.
    Haematologica. 2023;108:889-894.
    PubMed    


  57. PINCEZ T, Lo KS, D'Orengiani APHD, Garrett ME, et al
    Variation and impact of polygenic hematologic traits in monogenic sickle cell disease.
    Haematologica. 2023;108:870-881.
    PubMed     Abstract available


  58. CONRAN N
    Pain mechanisms in sickle cell disease. Are we closer to a breakthrough?
    Haematologica. 2023;108:663-664.
    PubMed    


  59. KHASABOVA IA, Gable J, Johns M, Khasabov SG, et al
    Inhibition of DAGLbeta as a therapeutic target for pain in sickle cell disease.
    Haematologica. 2023;108:859-869.
    PubMed     Abstract available


    February 2023
  60. SAKURAI M, Kogure Y, Mizuno K, Matsuki E, et al
    Long-term reduction in the incidence of aplastic anemia and immune thrombocytopenia during the COVID-19 pandemic.
    Haematologica. 2023 Feb 16. doi: 10.3324/haematol.2022.282351.
    PubMed     Abstract available


  61. HE Y, Guo X, Wang ZJ
    Therapeutic potential of beta-lactam ceftriaxone for chronic pain in sickle cell disease.
    Haematologica. 2023;108:633-637.
    PubMed    


  62. RAI P, Okhomina VI, Kang G, Akil N, et al
    The effects of cardio-selective beta blockade on diastolic dysfunction in children with sickle cell disease.
    Haematologica. 2023;108:594-598.
    PubMed    


    November 2022
  63. LIU YL, Shibuya A, Glader B, Wilkes MC, et al
    Animal models of Diamond-Blackfan anemia: updates and challenges.
    Haematologica. 2022 Nov 17. doi: 10.3324/haematol.2022.282042.
    PubMed     Abstract available


  64. AFZALI-HASHEMI L, Vaclavu L, Wood JC, Biemond BJ, et al
    Assessment of functional shunting in patients with sickle cell disease.
    Haematologica. 2022;107:2708-2719.
    PubMed     Abstract available


  65. LI X, Chatla S, Wilson AF, Wu L, et al
    Persistent DNA damage and oncogenic stress-induced Trem1 promotes leukemia in mice.
    Haematologica. 2022;107:2576-2588.
    PubMed     Abstract available


  66. ROSSATO P, Federti E, Matte A, Glantschnig H, et al
    Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
    Haematologica. 2022;107:2650-2660.
    PubMed     Abstract available


    October 2022
  67. HERNANDEZ G, Romero-Cortadellas L, Ferrer-Cortes X, Venturi V, et al
    Mutations in the RACGAP1 gene cause autosomal recessive congenital dyserythropoietic anemia type III.
    Haematologica. 2022 Oct 6. doi: 10.3324/haematol.2022.281277.
    PubMed     Abstract available


  68. GANGAT N, Bleeker J, Lynch D, Olteanu H, et al
    Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia.
    Haematologica. 2022;107:2523-2526.
    PubMed    


  69. GALADANCI NA, Johnson W, Carson A, Hellemann G, et al
    Factors associated with left ventricular hypertrophy in children with sickle cell disease: results from the DISPLACE study.
    Haematologica. 2022;107:2466-2473.
    PubMed     Abstract available


    September 2022
  70. BALDUINI CL
    Images from the Haematologica Atlas of Hematologic Cytology: schistocytes in thrombotic microangiopathies.
    Haematologica. 2022;107:2008.
    PubMed    


  71. KHWAJA J, D'Sa S, Minnema MC, Kersten MJ, et al
    IgM monoclonal gammopathies of clinical significance: diagnosis and management.
    Haematologica. 2022;107:2037-2050.
    PubMed     Abstract available


  72. GILAD O, Dgany O, Noy-Lotan S, Krasnov T, et al
    Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children.
    Haematologica. 2022;107:2081-2095.
    PubMed     Abstract available


    August 2022
  73. INVERNIZZI R
    Images from the Haematologica Atlas of Hematologic Cytology: congenital dyserythropoietic anemia type II.
    Haematologica. 2022;107:1736.
    PubMed    


  74. BENCHEIKH L, Nguyen KA, Chadebech P, Kiger L, et al
    Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell disease.
    Haematologica. 2022;107:1944-1949.
    PubMed    


  75. LEMAIRE B, Abramowski SW
    Alloimmunization against Fy3 is a serious threat in the era of cell therapy.
    Haematologica. 2022;107:1986-1987.
    PubMed    


  76. KNAUS A, Vergez F, Garcia C, Engels H, et al
    Occurrence of a paroxysmal nocturnal hemoglobinuria clone in an essential thrombocythemia: a link between PIGV and MPL.
    Haematologica. 2022;107:1989-1993.
    PubMed    


  77. LOPINTO J, Gendreau S, Berti E, Bartolucci P, et al
    Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis.
    Haematologica. 2022;107:1914-1921.
    PubMed     Abstract available


  78. GUTIERREZ-RODRIGUES F, Beerman I, Groarke EM, Patel BA, et al
    Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis.
    Haematologica. 2022;107:1815-1826.
    PubMed     Abstract available


    July 2022
  79. DE SOUZA LV, Hoffmann A, Fischer C, Petzer V, et al
    Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency.
    Haematologica. 2022 Jul 7. doi: 10.3324/haematol.2022.281149.
    PubMed     Abstract available


  80. INVERNIZZI R
    Images from the Haematologica Atlas of Hematologic Cytology: parvovirus-induced pure red cell aplasia.
    Haematologica. 2022;107:1493.
    PubMed    


  81. DERCHI G, Musallam KM, Pinto VM, Graziadei G, et al
    Tricuspid-valve regurgitant jet velocity as a risk factor for death in beta-thalassemia.
    Haematologica. 2022;107:1714-1718.
    PubMed    


  82. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
    Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results.
    Haematologica. 2022;107:1698-1702.
    PubMed    


  83. ALLARD P, Alhaj N, Lobitz S, Cario H, et al
    Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
    Haematologica. 2022;107:1577-1588.
    PubMed     Abstract available


  84. VERSTOVSEK S, Mesa R, Talpaz M, Kiladjian JJ, et al
    Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia.
    Haematologica. 2022;107:1599-1607.
    PubMed     Abstract available


  85. ABUGA KM, Muriuki JM, Uyoga SM, Mwai K, et al
    Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal Salmonella bacteremia.
    Haematologica. 2022;107:1589-1598.
    PubMed     Abstract available


    June 2022
  86. DONG P, Chen L, Wu H, Huo J, et al
    Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia.
    Haematologica. 2022 Jun 23. doi: 10.3324/haematol.2021.280292.
    PubMed     Abstract available


  87. RODEGHIERO F
    Introduction to a review series on the treatment of thrombocytopenic disorders: something old, something new.
    Haematologica. 2022;107:1239-1242.
    PubMed    


  88. NISHIMURA JI, Ando K, Masuko M, Noji H, et al
    Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2022;107:1483-1488.
    PubMed    


  89. KULOZIK AE
    Does the world need germline editing for beta-thalassemia?
    Haematologica. 2022;107:1235-1236.
    PubMed    


  90. GEISNESS AC, Azul M, Williams D, Szafraniec H, et al
    Ionophore-mediated swelling of erythrocytes as a therapeutic mechanism in sickle cell disease.
    Haematologica. 2022;107:1438-1447.
    PubMed     Abstract available


    May 2022
  91. XU ZL, Xu LP, Wu DP, Wang SQ, et al
    Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study.
    Haematologica. 2022 May 26. doi: 10.3324/haematol.2022.280758.
    PubMed     Abstract available


    April 2022
  92. ROSATO BE, Alper SL, Tomaiuolo G, Russo R, et al
    Hereditary anemia caused by multilocus inheritance of PIEZO1, SLC4A1 and ABCB6 mutations: a diagnostic and therapeutic challenge.
    Haematologica. 2022 Apr 21. doi: 10.3324/haematol.2022.280799.
    PubMed     Abstract available


  93. ALTINTAS B, Giri N, McReynolds LJ, Best A, et al
    Genotype-phenotype and outcome associations in patients with Fanconi anemia: The National Cancer Institute cohort.
    Haematologica. 2022 Apr 14. doi: 10.3324/haematol.2021.279981.
    PubMed     Abstract available


  94. BREGOLAT NF, Ruetten M, Da Silva MC, Aboouf MA, et al
    Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model.
    Haematologica. 2022 Apr 7. doi: 10.3324/haematol.2022.280732.
    PubMed     Abstract available


  95. BENNINGHOVEN-FREY KM, Neuhaus N, Lahtinen AK, Krallmann C, et al
    Early testicular maturation is sensitive to depletion of spermatogonial pool in sickle cell disease.
    Haematologica. 2022;107:975-979.
    PubMed    


    February 2022
  96. AVENOSO D, Marsh JCW, Potter V, Pagliuca A, et al
    SARS-CoV-2 infection in aplastic anemia.
    Haematologica. 2022;107:541-543.
    PubMed    


  97. ABDULMALIK O, Darwish NHE, Muralidharan-Chari V, Taleb MA, et al
    Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia.
    Haematologica. 2022;107:532-540.
    PubMed     Abstract available


  98. PINCEZ T, Fernandes H, Leblanc T, Michel G, et al
    Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden.
    Haematologica. 2022;107:457-466.
    PubMed     Abstract available


  99. CASALE M, Forni GL, Cassinerio E, Pasquali D, et al
    Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.
    Haematologica. 2022;107:467-477.
    PubMed     Abstract available


    January 2022
  100. BREWIN J, El Hoss S, Strouboulis J, Rees D, et al
    A novel index to evaluate ineffective erythropoiesis in hematological diseases offers insights into sickle cell disease.
    Haematologica. 2022;107:338-341.
    PubMed    


  101. TZOUNAKAS VL, Anastasiadi AT, Stefanoni D, Cendali F, et al
    Beta thalassemia minor is a beneficial determinant of red blood cell storage lesion.
    Haematologica. 2022;107:112-125.
    PubMed     Abstract available


    December 2021
  102. ELABBADI A, Voiriot G, Tristan A, Gibelin A, et al
    Lower respiratory tract infection with Staphylococcus aureus in sickle-cell adult patients with severe acute chest syndrome - the STAPHACS Study.
    Haematologica. 2021;106:3236-3239.
    PubMed    


    November 2021
  103. HOOGENBOOM WS, Fleysher R, Soby S, Mirhaji P, et al
    Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - a fifteen hospital observational study in the Bronx, New York.
    Haematologica. 2021;106:3014-3016.
    PubMed    


    October 2021
  104. BROUSSE V, Holvoet L, Pescarmona R, Viel S, et al
    Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?
    Haematologica. 2021;106:2746-2748.
    PubMed    


  105. VANDORPE DH, Shmukler BE, Ilboudo Y, Bhasin S, et al
    A Grammastola spatulata mechanotoxin-4 (GsMTx4)-sensitive cation channel mediates increased cation permeability in human hereditary spherocytosis of multiple genetic etiologies.
    Haematologica. 2021;106:2759-2762.
    PubMed    


  106. EL HOSS S, Cochet S, Godard A, Yan H, et al
    Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease.
    Haematologica. 2021;106:2707-2719.
    PubMed     Abstract available


    September 2021
  107. MUSALLAM KM, Vitrano A, Meloni A, Pollina SA, et al
    Survival and causes of death in 2,033 patients with non-transfusion-dependent beta-thalassemia
    Haematologica. 2021;106:2489-2492.
    PubMed    


  108. MIWATA S, Narita A, Okuno Y, Suzuki K, et al
    Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes.
    Haematologica. 2021;106:2511-2515.
    PubMed    


  109. LIZARRALDE-IRAGORRI MA, Lefevre SD, Cochet S, El Hoss S, et al
    Oxidative stress activates red cell adhesion to laminin in sickle cell disease.
    Haematologica. 2021;106:2478-2488.
    PubMed     Abstract available


  110. VENUGOPAL J, Wang J, Mawri J, Guo C, et al
    Interleukin-1 receptor inhibition reduces stroke size in a murine model of sickle cell disease.
    Haematologica. 2021;106:2469-2477.
    PubMed     Abstract available


  111. KOUNTOURIS P, Michailidou K, Christou S, Hadjigavriel M, et al
    Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.
    Haematologica. 2021;106:2458-2468.
    PubMed     Abstract available


    August 2021
  112. COLIN E, Courtois G, Brouzes C, Pulman J, et al
    Biallelic mutations in the SARS2 gene presenting as congenital sideroblastic anemia.
    Haematologica. 2021 Aug 19. doi: 10.3324/haematol.2021.279138.
    PubMed     Abstract available


  113. BOATENG LA, Schonewille H, Ligthart PC, Javadi A, et al
    One third of alloantibodies in patients with sickle cell disease transfused with African blood are missed by the standard red blood cell test panel.
    Haematologica. 2021;106:2274-2276.
    PubMed    


    July 2021
  114. WANG C, McGraw KL, McLemore AF, Komrokji R, et al
    Dual pyroptotic biomarkers predict erythroid response in lower risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin.
    Haematologica. 2021 Jul 29. doi: 10.3324/haematol.2021.278855.
    PubMed     Abstract available


  115. BEHRENS YL, Gohring G, Bawadi R, Coktu S, et al
    A novel classification of hematologic conditions in patients with Fanconi anemia.
    Haematologica. 2021 Jul 1. doi: 10.3324/haematol.2021.279332.
    PubMed     Abstract available


  116. LINDER GE, Chou ST
    Red cell transfusion and alloimmunization in sickle cell disease.
    Haematologica. 2021;106:1805-1815.
    PubMed     Abstract available


  117. KAUR K, Huang Y, Raman SV, Kraut E, et al
    Myocardial injury and coronary microvascular disease in sickle cell disease.
    Haematologica. 2021;106:2018-2021.
    PubMed    


  118. GILMARTIN AG, Groy A, Gore ER, Atkins C, et al
    In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor.
    Haematologica. 2021;106:1979-1987.
    PubMed     Abstract available


    June 2021
  119. BREWIN JN, Rooks H, Gardner K, Senior H, et al
    Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC).
    Haematologica. 2021;106:1770-1773.
    PubMed     Abstract available


  120. LAVINYA AA, Razali RA, Razak MA, Mohamed R, et al
    Homozygous Southeast Asian Ovalocytosis in five live-born neonates.
    Haematologica. 2021;106:1758-1761.
    PubMed     Abstract available


  121. MIKKELSEN SU, Safavi S, Dimopoulos K, O'Rourke CJ, et al
    Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance.
    Haematologica. 2021;106:1762-1766.
    PubMed     Abstract available


  122. SRISUWANANUKORN A, Han J, Raslan R, Gowhari M, et al
    Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease.
    Haematologica. 2021;106:1745-1748.
    PubMed     Abstract available


  123. SINGER ST, Fischer R, Allen I, Lal A, et al
    Pituitary iron and factors predictive of fertility status in transfusion dependent thalassemia.
    Haematologica. 2021;106:1740-1744.
    PubMed     Abstract available


  124. ALLALI S, Taylor M, Brice J, Montalembert M, et al
    Chronic organ injuries in children with sickle cell disease.
    Haematologica. 2021;106:1535-1544.
    PubMed     Abstract available


    May 2021
  125. PELLEGRIN S, Severn CE, Toye AM
    Towards manufactured red blood cells for the treatment of inherited anemia.
    Haematologica. 2021 May 27. doi: 10.3324/haematol.2020.268847.
    PubMed     Abstract available


  126. MESSONNIER LA, Riccetti M, Chatel B, Galacteros F, et al
    How to implement endurance exercise training in sickle cell disease.
    Haematologica. 2021;106:1476-1479.
    PubMed    


    April 2021
  127. ZAIMOKU Y, Patel BA, Shalhoub R, Groarke EM, et al
    Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag.
    Haematologica. 2021 Apr 29. doi: 10.3324/haematol.2021.278413.
    PubMed     Abstract available


  128. BROUSSE V, Pondarre C, Kossorotoff M, Arnaud C, et al
    Brain injury pathophysiology study by a multimodal approach in children with sickle cell anemia with no intra or extra cranial arteriopathy.
    Haematologica. 2021 Apr 22. doi: 10.3324/haematol.2020.278226.
    PubMed     Abstract available


  129. CORRE T, Ponte B, Pivin E, Pruijm M, et al
    Heritability and association with distinct genetic loci of erythropoietin levels in the general population.
    Haematologica. 2021 Apr 8. doi: 10.3324/haematol.2021.278389.
    PubMed     Abstract available


  130. CORRE T, Ponte B, Pivin E, Pruijm M, et al
    Heritability and association with distinct genetic loci of erythropoietin levels in the general population.
    Haematologica. 2021 Apr 8. doi: 10.3324/haematol.2021.278389.
    PubMed     Abstract available


  131. NANOU A, Toumpeki C, Fanis P, Bianchi N, et al
    Sex-specific transcriptional profiles identified in beta-thalassemia patients.
    Haematologica. 2021;106:1207-1211.
    PubMed    


    March 2021
  132. AL-SAMKARI H, Kessler CM, Auerbach M
    Recognition of thrombotic risk of thrombocytosis in iron deficiency
    Haematologica. 2021;106:661-663.
    PubMed    


  133. BAROZZI S, Di Buduo CA, Marconi C, Bozzi V, et al
    Pathogenetic and clinical study of a patient with thrombocytopenia due to the p.E527K gain-of-function variant of SRC.
    Haematologica. 2021;106:918-922.
    PubMed    


  134. BOUSSAID I, Le Goff S, Floquet C, Gautier EF, et al
    Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cells.
    Haematologica. 2021;106:746-758.
    PubMed     Abstract available


  135. JIMENEZ K, Leitner F, Leitner A, Scharbert G, et al
    Iron deficiency-induced thrombocytosis increases thrombotic tendency in rats.
    Haematologica. 2021;106:782-794.
    PubMed     Abstract available


    February 2021
  136. KORPORAAL A, Gillemans N, Heshusius S, Cantu I, et al
    Hemoglobin switching in mice carrying the Klf1(Nan) variant.
    Haematologica. 2021;106:464-473.
    PubMed     Abstract available


    January 2021
  137. LIU Y, Dahl M, Debnath S, Rothe M, et al
    Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector.
    Haematologica. 2021 Jan 14. doi: 10.3324/haematol.2020.269142.
    PubMed     Abstract available


  138. STONE EF, Avecilla ST, Wuest DL, Lomas-Francis C, et al
    Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy.
    Haematologica. 2021;106:310-312.
    PubMed    


  139. BLOMBERY P, Fox L, Ryland GL, Thompson ER, et al
    Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
    Haematologica. 2021;106:64-73.
    PubMed     Abstract available


  140. BRODSKY RA, Peffault de Latour R, Rottinghaus ST, Roth A, et al
    Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2021;106:230-237.
    PubMed     Abstract available


    December 2020
  141. BARCIA G, Pandithan D, Ruzzenente B, Assouline Z, et al
    Biallelic IARS2 mutations presenting as sideroblastic anemia.
    Haematologica. 2020;Online ahead of print:0.
    PubMed     Abstract available


  142. KIETZMANN T
    Hypoxia-inducible erythropoietin expression: details matter.
    Haematologica. 2020;105:2704-2706.
    PubMed    


    November 2020
  143. ATAGA KI, Zhou Q, Derebail VK, Saraf SL, et al
    Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysis.
    Haematologica. 2020;Online ahead of print.
    PubMed     Abstract available


  144. BALDUINI CL
    100-year-old Haematologica images: bothriocephalus and pernicious anemia.
    Haematologica. 2020;105:2497.
    PubMed    


  145. MENAPACE LA, Thein SL
    COVID-19 and sickle cell disease.
    Haematologica. 2020;105:2501-2504.
    PubMed    


    October 2020
  146. TELEN MJ
    Pyridoxamine: another vitamin for sickle cell disease?
    Haematologica. 2020;105:2348-2350.
    PubMed    


    September 2020
  147. PATEL BA, Ghannam J, Groarke EM, Goswami M, et al
    Detectable mutations precede late myeloid neoplasia in aplastic anemia.
    Haematologica. 2020;Online ahead of print.
    PubMed    


  148. TELFER P, De la Fuente J, Sohal M, Brown R, et al
    Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients.
    Haematologica. 2020;Online ahead of print.
    PubMed    


  149. MODEPALLI S, Hattangadi SM
    Novel use for selective inhibitors of nuclear export in beta-thalassemia: block of HSP70 export from the nucleus via exportin Xpo1 improves ineffective erythropoiesis.
    Haematologica. 2020;105:2188-2189.
    PubMed    


    July 2020
  150. IMMACOLATA ANDOLFO, Stefania Martone, Michela Ribersani, Simona Bianchi, et al
    Apparent recessive inheritance of sideroblastic anemia type 2 due to uniparental isodisomy at the SLC25A38 locus.
    Haematologica. 2020;105:2883-2886.
    PubMed    


  151. GIRELLI D, Busti F
    Replacing the suppressed hormone: toward a better treatment for iron overload in beta-thalassemia major?
    Haematologica. 2020;105:1752-1754.
    PubMed    


    June 2020
  152. SUBARNA CHAKRAVORTY, Giselle Padmore-Payne, Fester Ike, Virginia Tshibangu, et al
    COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.
    Haematologica. 2020;105:2691-2693.
    PubMed    


    March 2020
  153. NARLA A, Mohandas N
    Staying hydrated is important also for erythroblasts.
    Haematologica. 2020;105:528-529.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.